DB
NVAX icon

Dmitry Balyasny’s Novavax NVAX Stock Holding History

Dmitry Balyasny’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,700
Closed -$301K – 3414
2025
Q3 		$301K Sell
34,700
-44,300
-56% -$345K ﹤0.01% 2577
2025
Q2 		$498K Buy
79,000
+42,300
+115% +$280K ﹤0.01% 2291
2025
Q1 		$235K Sell
36,700
-21,000
-36% -$174K ﹤0.01% 2534
2024
Q4 		$464K Buy
+57,700
New +$556K ﹤0.01% 2224

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Dmitry Balyasny's NVAX Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Novavax (NVAX) in Q2 2026: 82,240 shares worth $775K. The stake represents ﹤0.01% of the portfolio and ranks #2345 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in NVAX as recently as Q4 2025.

Dmitry Balyasny first reported a position in NVAX in Q3 2015 and has held it in 15 quarters since. The position peaked at $18M in Q2 2021. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Dmitry Balyasny held 82,240 shares of Novavax worth $775K as of Q2 2026.
  • Novavax was a new Dmitry Balyasny position in Q2 2026.
  • Novavax made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2345 holding.
  • Dmitry Balyasny first reported a position in Novavax in Q3 2015 and has held it in 15 quarters since.
  • Dmitry Balyasny's Novavax position peaked at $18M in Q2 2021.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.